GlassScriptPhysician profile
Braden James Webb
NPI 1245762061
$11,781.09
in general payments reported to CMS, 2019-2025
26 companies · $1,770 in 2025
The $1,770 reported for 2025 was more than what 80% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.66 · 2021: $2,042 · 2022: $2,826 · 2023: $2,772 · 2024: $2,279 · 2025: $1,770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,980 · Travel and Lodging: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,980.40 |
| Travel and Lodging | $840.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,899.66 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Medtronic, INC. | $2,583.16 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Relievant Medsystems, INC. | $1,288.14 | 2022-2023 | Intracept |
| Mml US, INC. | $706.09 | 2022-2025 | Reactiv8 |
| Saluda Medical Americas, INC. | $686.42 | 2023-2025 | Evoke, Evoke Scs |
| Biotronik Nro, INC. | $294.42 | 2025 | Prospera |
| Spr Therapeutics, INC | $211.31 | 2022-2024 | Sprint Pns System |
| Globus Medical, INC. | $175.06 | 2025 | Senza |
| Painteq LLC | $134.29 | 2022-2023 | Painteq |
| Bioventus LLC | $121.81 | 2022 | |
| Abbvie INC. | $116.64 | 2022-2025 | |
| Vertos Medical, INC. | $100.00 | 2023 | Mild Device Kit |
| Depuy Synthes Sales INC. | $73.35 | 2023-2024 | Orthovisc, Monovisc, Peak |
| Collegium Pharmaceutical, INC. | $67.34 | 2023 | Xtampza, Belbuca |
| Vertex Pharmaceuticals Incorporated | $51.89 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $35.82 | 2023 | Gralise |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.34 | 2023 | Relistor |
| Indivior INC. | $31.42 | 2024 | Sublocade |
| Nalu Medical, INC. | $30.75 | 2023-2024 | Nalu Neurostimulation System |
| Pfizer INC. | $28.62 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.77 | 2022 | |
| Allergan, INC. | $23.70 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.94 | 2024 | Caplyta |
| Impel Pharmaceuticals INC. | $17.93 | 2022 | |
| Stryker Corporation | $14.26 | 2024 | Spinejack, Omnicurve |
| Lilly USA, LLC | $11.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Braden Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.